250 related articles for article (PubMed ID: 31683170)
1. Potential role of microbiome in oncogenesis, outcome prediction and therapeutic targeting for head and neck cancer.
Orlandi E; Iacovelli NA; Tombolini V; Rancati T; Polimeni A; De Cecco L; Valdagni R; De Felice F
Oral Oncol; 2019 Dec; 99():104453. PubMed ID: 31683170
[TBL] [Abstract][Full Text] [Related]
2. The Microbiome's Influence on Head and Neck Cancers.
Dorobisz K; Dorobisz T; Zatoński T
Curr Oncol Rep; 2023 Mar; 25(3):163-171. PubMed ID: 36696075
[TBL] [Abstract][Full Text] [Related]
3. The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?
Reis Ferreira M; Pasto A; Ng T; Patel V; Guerrero Urbano T; Sears C; Wade WG
Cancer Treat Rev; 2022 Sep; 109():102442. PubMed ID: 35932549
[TBL] [Abstract][Full Text] [Related]
4. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study.
Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H
Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434
[TBL] [Abstract][Full Text] [Related]
5. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs in head and neck cancer.
Li X; Cao Y; Gong X; Li H
Oncotarget; 2017 Feb; 8(6):10726-10740. PubMed ID: 27802187
[TBL] [Abstract][Full Text] [Related]
7. Oral microbiome, periodontitis and risk of head and neck cancer.
Galvão-Moreira LV; da Cruz MC
Oral Oncol; 2016 Feb; 53():17-9. PubMed ID: 26684542
[TBL] [Abstract][Full Text] [Related]
8. Oral microbiome and risk of incident head and neck cancer: A nested case-control study.
Wu Z; Han Y; Wan Y; Hua X; Chill SS; Teshome K; Zhou W; Liu J; Wu D; Hutchinson A; Jones K; Dagnall CL; Hicks BD; Liao L; Hallen-Adams H; Shi J; Abnet CC; Sinha R; Chaturvedi A; Vogtmann E
Oral Oncol; 2023 Feb; 137():106305. PubMed ID: 36610232
[TBL] [Abstract][Full Text] [Related]
9. Investigational drugs for head and neck cancer.
Bossi P; Alfieri S
Expert Opin Investig Drugs; 2016 Jul; 25(7):797-810. PubMed ID: 27054910
[TBL] [Abstract][Full Text] [Related]
10. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
11. Is There an Interplay between Oral Microbiome, Head and Neck Carcinoma and Radiation-Induced Oral Mucositis?
Gugnacki P; Sierko E
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885015
[TBL] [Abstract][Full Text] [Related]
12. The human microbiome and its link in prostate cancer risk and pathogenesis.
Katongole P; Sande OJ; Joloba M; Reynolds SJ; Niyonzima N
Infect Agent Cancer; 2020; 15():53. PubMed ID: 32884579
[TBL] [Abstract][Full Text] [Related]
13. Beyond Head and Neck Cancer: The Relationship Between Oral Microbiota and Tumour Development in Distant Organs.
Mascitti M; Togni L; Troiano G; Caponio VCA; Gissi DB; Montebugnoli L; Procaccini M; Lo Muzio L; Santarelli A
Front Cell Infect Microbiol; 2019; 9():232. PubMed ID: 31297343
[TBL] [Abstract][Full Text] [Related]
14. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer.
Chattopadhyay I; Verma M; Panda M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819867354. PubMed ID: 31370775
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].
Laban S; Doescher J; Schuler PJ; Bullinger L; Brunner C; Veit JA; Hoffmann TK
HNO; 2015 Sep; 63(9):612-9. PubMed ID: 26319429
[TBL] [Abstract][Full Text] [Related]
16. Nutrition impact symptoms and associated outcomes in post-chemoradiotherapy head and neck cancer survivors: a systematic review.
Crowder SL; Douglas KG; Yanina Pepino M; Sarma KP; Arthur AE
J Cancer Surviv; 2018 Aug; 12(4):479-494. PubMed ID: 29556926
[TBL] [Abstract][Full Text] [Related]
17. The Microbiome: the Link to Colorectal Cancer and Research Opportunities.
Cass SH; Ajami NJ; White MG
Curr Treat Options Oncol; 2022 May; 23(5):631-644. PubMed ID: 35254596
[TBL] [Abstract][Full Text] [Related]
18. Identification and evaluation of the microbiome in the female and male reproductive tracts.
Koedooder R; Mackens S; Budding A; Fares D; Blockeel C; Laven J; Schoenmakers S
Hum Reprod Update; 2019 May; 25(3):298-325. PubMed ID: 30938752
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in head and neck cancer: A Mini Review.
Silva Galbiatti-Dias AL; Pavarino ÉC; Kawasaki-Oyama RS; Maniglia JV; Maniglia EJ; Goloni Bertollo EM
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):39-43. PubMed ID: 26518895
[TBL] [Abstract][Full Text] [Related]
20. [The microbiome in head and neck tumors-initial findings and outlook].
Lang S; Brandau S; Marchesi JR; Jablonska J; Thurnher D; Mattheis S; Buer J; Hussain T
HNO; 2020 Dec; 68(12):905-910. PubMed ID: 32995898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
